Building a Smokeless World is a continuous journey. Omni™ 2026 charts our progress as we turn years of research into real world policy impact. From launching our first vapour products in 2013 to compiling more than 260 peer reviewed studies in 2024, that momentum continues with the release of Omni™ 2026. This latest evolution moves beyond a scientific repository and gives policymakers actionable insights. Review the evidence. Join the conversation. Download Omni™ 2026: ow.ly/F1mS5100VgI Omni™ is intended for scientists, public health authorities, regulators, policymakers, and investors only, and is not intended for consumers.

The Smokeless Word: Live from the Lab with Dr James Murphy is back! And this time he’s joined by economist Professor Douglas Deng, whose research explores how the tobacco industry is evolving as next-generation products reshape the market. His message for governments across Asia: “It is not very easy to get a one-size-fits-all solution for different countries.” But an evidence-based framework is a must. Join James and Professor Deng as they explore what that means in practice, including the realities of tobacco-growing economies and the lessons from Japan’s heated tobacco market. Tune in now: ow.ly/fe1A51001jg

Greece shows what happens when regulators allow for an objective assessment of the science-based evidence and independent verification of reduced‑risk messages. Since implementing this framework, adult smoking rates fell by 10% from 2020–2024, while heated product adoption doubled. Jochen Hiller, cluster manager of our Greek market team, outlines the case study below. Download the New Omni™ 2026 Edition*: asmokelessworld.com/gb/en?ut… #Omni #SmokelessWorld #NewOmni2026Edition *Omni™ is intended for scientists, public health authorities, regulators, policymakers, and investors only, and is not intended for consumers.

Same goal. Different approaches. Different outcomes. The UK & Netherlands share the same goal: to reduce smoking prevalence. But their approaches to nicotine regulation are associated with different outcomes. Read the full case study in the New Omni™ 2026 Edition*: ow.ly/QY7o50ZXwpF *Omni™ is intended for scientists, public health authorities, regulators, policymakers, and investors only, and is not intended for consumers.

70% of South Africans once believed in democracy. Now it's only 36%. That shift matters well beyond the polling station. On the latest episode of The Smokeless Word, South Africa's former Statistician-General, Pali Lehohla, draws on HSRC survey data to explore what fading public trust could mean for elections and broader society. His warning is stark: if turnout falls to 20-30%, "democracy collapses" A sobering look at what's at stake when public confidence erodes. Watch the full episode now: ow.ly/nVLi50ZXvVH

Could this cause harm? That's hazard. How likely is harm under real conditions of exposure? That's risk. Danni Tower, Group Head of Scientific Affairs at BAT, on a distinction explored in the New Omni™ 2026 Edition – out now. ow.ly/OGlg50ZWN8Z Omni™ is intended for scientists, public health authorities, regulators, policymakers, and investors only, and is not intended for consumers

The latest episode of The Smokeless Word is officially live. This week, Kingsley Wheaton sits down with South Africa's former Statistician-General, Pali Lehohla, to explore how data shapes a nation's story, strength and future. From leading South Africa’s post-apartheid censuses to thinking about what comes next, Pali asks a hard question: what is his generation handing over to the next and what will they hand over in turn? Tune in for a conversation about legacy, national progress and long-term vision. Watch now: ow.ly/hFtM50ZWcH4

When governments enable evidence-led communication, public health benefits. Our newly updated Omni™ 2026 edition features an updated look at Greece, where landmark legislation in 2020 created a framework for communicating government approved risk reduction information to adult consumers at the point of sale. Since then, daily smoking rates have dropped while adoption of reduced risk profile alternatives has grown. Greece shows what happens when policy allows adult smokers who would otherwise continue to smoke to access scientific facts and information. Review the evidence. Join the conversation. Download the New Omni™ 2026 Edition today. Omni™ is intended for scientists, public health authorities, regulators, policymakers, and investors only, and is not intended for consumers.

Building a Smokeless World requires clear goals and measurable progress. The New Omni™ 2026 Edition outlines our transformation as we shift our business toward potentially reduced risk smokeless alternatives for adult smokers who would otherwise continue to smoke. Omni™ is intended for scientists, public health authorities, regulators, policymakers, and investors only, and is not intended for consumers. Download: ow.ly/6HKm50ZTQ3y

Today, BAT’s Chief Executive, Tadeu Marroco, is hosting our 2026 Capital Markets Day in Winston-Salem, North Carolina, USA. Our CMD is an opportunity to hear from our Management Board and senior leaders about the capabilities, the people, the belief, and the ambitions that are shaping our future. Presentations will start today at 13:00 BST (08:00 EDT) and there will be a live webcast on BAT.com. To register for the webcast, please visit: ow.ly/3VW650ZQ9KC

BAT’s Chief Executive, Tadeu Marroco, is hosting our 2026 Capital Markets Day next week in Winston-Salem, North Carolina, USA. Our CMD is an opportunity to hear from our Management Board and senior leaders about the capabilities, the people, the belief, and the ambitions that are shaping our future. Presentations will start on Tuesday 29th September at 13:00 BST (08:00 EDT) and there will be a live webcast on BAT.com. To register for the webcast, please visit: ow.ly/vuiA50ZQ9CU

5% strategy. 95% execution. That's how you transform a 125-year-old business according to BAT's Chief Executive. Tadeu Marroco, joins The @SmokelessWord for a masterclass in how to make decisions and then get on with turning direction into success. Catch the trailer below.

Infrastructure. Trust. Evidence. The transition away from combustion needs all three at once. It also needs regulators and science pulling the same way. Download the New Omni™ 2026 Edition today: ow.ly/tpgm50ZPGYE For scientists, public health authorities, regulators, policymakers, and investors.

Progress on Tobacco Harm Reduction relies on informed discussion grounded in science and evidence. Highlights from GTNF in Lisbon, where the New Omni™ 2026 Edition was unveiled by our Chief Corporate Officer, Kingsley Wheaton. Download the New Omni™ 2026 Edition now: ow.ly/gGn950ZL8KR.

When governments enable evidence based communication, they can support better informed public health decision-making. That's the case we make in the New Omni™ 2026 Edition - updated, expanded, and out now. Download the New Omni™ 2026 Edition now: ow.ly/tkpf50ZLe9P. Omni™ is intended for scientists, public health authorities, regulators, policymakers, and investors only, and is not intended for consumers.

Coming soon: the New Omni™ 2026 Edition. Omni™ is intended for scientists, public health authorities, regulators, policymakers and investors. It is not intended for consumers. Building on the foundations established in the previous edition, Omni™ 2026 continues to advance evidence-based discussion and engagement on tobacco harm reduction and related scientific issues.

Our Half Year 2026 Results are now live: ow.ly/jmiB50ZuxSV. Join today's conference call at 9:30am BST, hosted by CEO Tadeu Marroco, Interim CFO Javed Iqbal Syed and Group Head of IR Victoria Buxton: ow.ly/QW3250ZuxSU. #HYR26 #BAT #Results

We will publish our Half Year 2026 Results on Thursday 30 July at 7am BST. Our Chief Executive Tadeu Marroco, Interim Chief Financial Officer Javed Iqbal Syed, and Group Head of Investor Relations Victoria Buxton, will host a conference call at 9.30am BST. For more details and to join the webcast visit: ow.ly/rW8s50ZrQmj #HYR26 #BAT #Results #InvestorRelations